C. Aranow et al., CLINICALLY OCCULT AVASCULAR NECROSIS OF THE HIP IN SYSTEMIC LUPUS-ERYTHEMATOSUS, Journal of rheumatology, 24(12), 1997, pp. 2318-2322
Objective. To study the natural history of clinically occult avascular
necrosis (AVN) of the hip in patients with systemic lupus erythematos
us (SLE). Methods. Sixty-six patients with SLE (without symptoms refer
able to the hip) receiving at least 5 mg/day prednisone for greater th
an or equal to 6 months were screened by magnetic resonance imaging (M
RI) for AVN of the hip. A complete MRI evaluating class and percentage
of femoral head involvement, AP and lateral radiographs of the hips,
bone scant and physical examination were performed for patients with p
ositive MRI. Medical records were reviewed for serologic and clinical
variables that might predict AVN. Repeat MRI were obtained at 3, 6, an
d 12, months to assess possible progression or resolution of the lesio
n. Patients with negative screening MRI underwent repeat screening aft
er one year to assess the one year incidence rate. Results. Eleven asy
mptomatic hips (8%) in 8 patients (12%) had MRI documented AVN. The pe
rcentage of femoral head involvement ranged from 1 to 46%. One lesion
was MRI class B, the remaining lesions were class A. The radiographic
stage of 10 hips was stage 1, the MRI class B hip was stage 2. Risk fa
ctors for clinically occult AVN included Afro-American origin, Raynaud
's phenomenon, migraine headaches, and a maximal corticosteroid dose o
f at least 30 mg/day. After 12 months, 43 of 58 patients with an initi
ally negative MRI underwent repeat screening examinations; no new lesi
ons were observed. Conclusion. Clinically occult AVN of the hip is com
mon in patients with SLE. The short term natural history of these lesi
ons appears stable without spontaneous healing or clinical or radiogra
phic progression. Risk factors for these asymptomatic lesions ore simi
lar to the risks for symptomatic AVN and surgical intervention appears
not to be indicated in these patients.